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(Director : Prof. Dr. R1K10 YAMAKI) 
In dogs, 4.0cm of abdominal aorta below the confluence of the renal arteries was 
excised and replaced with 5.0 cm of human umbilical cord vein (HUCV) graft treated 
with the following techniques : Group I , tanned with 1 % glutaraldehyde (GA) and 
preserved in the same solution ; Group H, tanned with 1% GA for 24 hours and preserved 
in 50 % ethanol (ET) ; Group DI, tanned in the same manner as Group H , but preserved 
in 70 % ET ; Group N, tanned with 0.5 % GA for 24 hours and preserved in 50% ET ; 
and Group V, tanned as in Group N but preserved in 70% ET. 
Patency was evaluated by aortography two weeks, and one, three and six months after 
implantation. At autopsy (after intervals of two weeks to six months) the graft was opened 
longitudinally and its patency redetermined. The pseudointima covering the internal surface 
of the graft was examined by direct insepection and by light-and scanning electron-micro-
graphies. 
In order to determine the antigenicity of the graft, cytotoxic tests were performed 
before, two weeks, and one, three and six months after implantation, using human cultured 
lymphoblasts taken from Burkit lymphomas. 
Results 
1) The highest patency rate, 100% (8/8), was obtained in Group DI, while the 
lowest, 62. 5% (5/8), was in Group I . However, no statistically significant differences 
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were found among the five groups. The graft tended to become fragile after preservation 
in the GA solution. 
2) It was shown aortographically that most of the suture lines gradually contracted. 
Six months after implantation, the incidence of this finding was as high as 83.3% (5/6). 
3) Two weeks after replacement, a nearly homogeneous, reddish fibrin membrane 
covered the whole inner surface of the graft. This membrane gradually turn巴d into a 
glossy, yellowish sheet. At both ends of the graft, beltlike, whitish tissue, i.e., pannuses, 
were seen in a month and extended gradually, in six months being only 5 mm wide. 
4) Microscopically, the structural integrity of the graft was well preserved with 
minimal host cell ingrowth even six months after implantation. The irregular fibrin mem-
hrane covering the entire inner surface of the graft became smoother and thinner with the 
lapse of time. The pannus increased gradually both in thickness and width. 
5) Scanning electron-micrography of the graft revealed that the fibrin network covering 
the inner surface of the graft was coarse at first, but later became fine, because the fibrin 
fibers progressively conglutinat巴d. In the areas close to the suture lines, oval immature 
endothelial cells with many microvilli, arranged in the direction of the blood flow, begun 
to appear in a month and had completely fused into a smooth sheet in six months. However, 
a short distance from the anastomoses, these cells were connected only by pseudopodlike 
processes. No endothelial cells were found more than 5 mm from the suture lines. 
6) Cytotoxic tests showed that antigenicity of the graft was effectively suppressed 
with glutaraldehyde regardless of whether its concentration was 0.5 % or 1.0°ム This
coincided well with the microscopic finding of minimal host cell ingrowth. 

































2時間保脊した後， ethanol系列で脱水し，その後，百群： 0.5%glutaraldehyde処理， 50% ethanol 
保存．







































0.2M cacodylate緩衝液， 0.4M saccharose液の等
量混合液で20分間隔で数回洗浄し， 4°Cで24時間保存，
ついで， 2%osmic acid, 0.2M cacodylate緩衝液，
Millonig’s phosphate緩衝液の等量混合液中K4℃で
isoamylacetate液に15分間浸し， 目立臨界点乾燥装
置 HCP-1 を用い，液化炭酸ガスで乾燥し， EIKO 










atorie Inc, U.S.A）を追加した RPMI1640培養液


















は， I群 62.5% (5/8)' Il群 87.5%(7/8), I群 100











Groups Dog No. 
Table 1. Patency rates of differently treated HUCV本 grafts
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Fig. 1. Aortograms after replacement. Arrows indicate the anastomotic lines. A. After 3 months. 
No stenosis is seen at either end of the graft. B. After 2 weeks. Slight to moderate 
narrowing. C. After 6 months. Severe stenosis of the proximal end of the graft is shown. 
Fig. 2. Aortogram six months after replacement shows moderate anastomotic 
stenoses (straight arrows) and mural irregularity of the graft (curved 













Table 2. Relationship between anastomotic 





















沢ある淡黄色のものに変化しつつあった． pannus l:t 
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Fig. 3. Internal surfaces of HUCV grafts opened longitudinally. •A. Two weeks after implantation. 
An巴ar!yhomogeneous reddish fibrin membrane is seen over the entire surface. B. After a 
month. At both ends of the graft, pannuses, i.e., beltlike, whitish tissue, have grown from 
the aortic intima of the host. The reddish, fibrin membrane is gradually turning into a 
glossy, yellowish sheet. C. and D. Three and six months after implantation, respectively. 
The pannus is extending. 
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Scanning electron micrograph of the inner surface 
of a HUCV graft treated with 1 % glutaraldehyde 
solution and subsequently preserved in 70° ~ ethanol. 
The subintimal layer is exposed due to the des-
quamation of the intimal lining. (Original magnific-
a tion，×1000) 
Fig. 7. Scanning electron micrographs of the inner surface of a HU
CV graft two weeks after 
implantation. A coarse fibrin network, in which erythrocytes, leucoc
ytes and platelets 
(arrows) are caught, covers)he entire inner surface. A. Original magnification，
×100. 
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Fig. 9. Scanning electron micrographs of the inner surface of a HUCV graft six months after 
replacement (Original magnification, x 1000). A. In the area close to the anastomotic 
line, endothelial cells have completely fused into a smooth sheet. B. In the area slightly 
away from the anastomosis, these cells are connected only by pseudopodlike processes. 
The arrow indicates an endothelial cel. 
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Fig. 10. Scanning electron micrographs of the inner surface of a HUCV graft three months after 
implantation. A. In the mid portion of the graft, the fibrin network has become much 
more compact than that seen two weeks after replacement. ( Or;ginal magnification, >'.100) 
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Fig. 1. Scanning electron micrographs of the inner surface of a HUCV graft six months after 
ir叩 lantation. The f伽 innetwork, even in the mid-portion of the graft, has b叩me
much denser when compared with th3t seen after thr巴emonths. A. Original magmtica-
tion, x 1000. B. Higher magnification of the rectangulal area in A，×3000. 
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Table 3. Incid-ence of dead cells in cytotoxic tests 
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Fig. 12. Cytotoxic tests. A. Before implantation. The cellular death rate is about 12°1.. Single and 
double arrows indicate dead and living cells, respectively. B. Three months aft巴rimplanta-


































て， 1）機械的特性の保全， 2) collagenの変性防止


























dialdehydestarch を， Dardikらは， 濃度を発表し
ていないが，稀釈した glutaraldehydeを推奨してい
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